Medytox Co., Ltd.
Innotox 50 Units
Next-Generation Ready-to-Use Liquid Botox
Presenting Innotox 50, the first liquid Botox Solution! One of the Innotox versions has 50U of botulinum toxin type A complex. Medytox, a well-known biopharmaceutical company, was proudly created in South Korea.
Innotox is available in 1 x 50U vial.
Product Description
About Innotox 50 Units
Medytox, a well-known South Korean biopharmaceutical company, developed Innotox 50U in 2014, and it has since garnered popularity. It contains Clostridium botulinum type A, a toxin that relaxes and stops facial muscle contraction. Non-animal stabilizers are also added in its manufacture to limit the danger of illnesses caused by blood-derived substances such as human serum albumin.
Furthermore, Medytox established its global status for the botulinum toxin market by being the first Korean business to effectively create the toxin. Innotox 50 is manufactured utilizing cutting-edge technology that is widely regarded worldwide, and Medytox has secured its largest license-out contract in Korea's pharmaceutical business.
Innotox 50U is a ready-to-use, sterile liquid. As a result, there is no chance of contamination or incorrect dosing owing to human error during reconstitution, which improves the treatment's safety and efficacy. Innotox 50U does not require dilution, making it relatively simple to administer and lowering the possibility of errors during administration. The following is a comparison of how Botox products are administered, and how Innotox 50U is significantly easier to use because it has no dilution.
Innotox 50U addresses drooping skin, noticeable facial wrinkles, and a range of other flaws. Its fame stems from the fact that it was the first liquid Botox to be introduced. In addition to reducing facial wrinkles, Innotox 50U can cure hand, foot, and armpit hyperhidrosis, as well as brow blepharospasm. Additionally, because of its slow rate of diffusion, the neurotoxin cannot harm nearby tissues.
Why Choose This Product
Key Benefits of Innotox 50 Units
Next-Generation Liquid Formula
- It is the next generation of Botox solutions, serving as the first liquid formulation of botulinum toxin type A in history.
- Because it does not require dilution, the solution is simple to use and lowers the risk of hygiene problems during preparation.
Safe & HSA-Free
- It is a safe solution to administer because it does not contain human serum albumin (HSA) or animal-derived compounds.
- Clinical trials have proven its safety and efficacy in lowering the visibility of glabellar wrinkles.
Easy & Accurate Dosing
- Innotox makes it straightforward to quantify the recommended dosage of 0.1 mL or four units of botulinum toxin solution.
- With its exceptional R&D skills, the Innotox solution has elevated the standard for Botox formulation on the market.
Regulatory Approval
- The Ministry of Food and Drug Safety in South Korea gave its approval in 2013.
Treatment Areas
Scope of Application
Glabella lines
Forehead lines
Crow's feet
Blepharospasm
Mimic wrinkles
Nasolabial folds
Marionette lines
Jaw reduction
Neck or platysmal bands
Hyperhidrosis (palms, armpits, and feet)
Results Timeline
Duration of Effect
Innotox 50U primarily inhibits muscle contraction and can last 6 to 12 months when treatment sessions are completed regularly.
Composition
Product Composition
Innotox contains 50U of Clostridium botulinum Type A strain.
During the production of Innotox, the type A strain of Clostridium botulinum is produced in a reputable laboratory that ensures non-animal-derived substances are used in the formulation. The goal is to eliminate the dangers associated with animal-based proteins. Furthermore, it excludes human serum albumin as an excipient to avoid any risks associated with blood-borne diseases. The formula contains only natural stabilizers, such as methionine and polysorbate, to ensure long-term effects and safety.
Technical Details
Specifications of Innotox 50 Units
| Packaging | 1 x 50U (1.25mL) vial |
|---|---|
| Composition | Clostridium Botulinum Toxin Type A – Liquid type (No need for dilution) + L-polysorbate and methionine as stabilizers |
| Indications | Innotox 50U primarily improves moderate to severe glabellar wrinkles related to eyebrow wrinkle muscle (corrugator muscle) and procerus muscle activity in adults aged 20 to 65. |
| Method of Administration | Intradermal to the larger muscle layers |
| Cannula size | 30G |
| Recommended dosage | The recommended dose is usually 0.5mL to 20 units per session. But it will still depend on your doctor's discretion and the target area. Your doctor will base his dosing on the recommended concentration of Innotox, which is 4U/0.1mL. |
| Treatment interval | Allow 2 weeks between each treatment. When repeating, allow another full session after 3 months, and no sooner. |
| Duration of effect | 6~12 months |
| Storage | Store at 2 to 8℃ or refrigerated in its hermetic container. |
| Shelf life | 36 months from manufacturing date |
| Manufacturer | Medytox Co., Ltd. |
Source Innotox 50 Units
Ready to Order Innotox 50 Units?
Connect with our team to request pricing, availability, and wholesale sourcing information for Innotox 50 Units and our full range of premium Korean botulinum toxin products.